Sunday January 24, 2021
  • |Subscribe
  • |Contribute
  • |About
  • |Access Your Account
  • |Register
  • |Login
  • |Home
  • |Current Issue
  • |Issue Archive
    • |Featured Reports
    • |eBooks
  • |BioProcess Insider
  • |Multimedia
    • |BPI White Papers
    • |Webinars
    • |Posters
  • |BioProcess International Events
    • |BioProcess International West
    • |COVID-19 Therapeutic Development & Production
  • |BioProcess International Academy
  • |Events

BioProcess International

Covering the whole development process for the global biotechnology industry

  • Upstream
    Processing
    Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
    • Assays
    • Biochemicals/Raw Materials
    • Bioreactors
    • Cell Culture Media
    • Expression Platforms
    • Fermentation
    • Perfusion Cell Culture
    • Upstream Contract Services
    • Upstream Single-Use Technologies
  • Downstream
    Processing
    Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
    • Filtration
    • Separation/Purification
    • Viral Clearance
    • Chromatography
    • Downstream Contract Services
    • Downstream Single-Use Technologies
  • Manufacturing
    Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
    • Personalized Medicine
    • Single Use
    • Supply Chain
    • Vaccines
    • MAb
    • Biosimilars
    • Cell/Gene Therapies
    • Emerging Therapeutics
    • Facility Design/Engineering
    • Continuous Bioprocessing
    • Fill/Finish
    • Formulation
    • Information Technology
    • Manufacturing Contract Services
    • Process Monitoring and Controls
  • Analytical
    Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
    • Culture Development
    • Cell Line Development
    • Downstream Development
    • Downstream Validation
    • Laboratory Equipment
    • PAT
    • Pre-Formulation
    • Product Characterization
    • QA/QC
    • Upstream Development
    • Upstream Validation
    • Leachables/Extractables/Particulates
  • Business
    Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
    • Careers
    • CMC Forums
    • Economics
    • Intellectual Property
    • Pre-Clinical and Clinical Trials
    • Regulatory Affairs
    • Risk Management
    • BioRegions

May 2005

BPI Reports

by BPI Contributor
Add Comment
May 1, 2005

Strategies To Address Aggregation During Protein A Chromatography

by BPI Contributor
Add Comment
May 1, 2005

Products, Services, and Literature

by BPI Contributor
Add Comment
May 1, 2005

High-Pressure Disaggregation and Folding of Recombinant Proteins

by BPI Contributor
Add Comment
May 1, 2005

Global Meetingplace

by BPI Contributor
Add Comment
May 1, 2005

From Farming to Fermentation

by BPI Contributor
Add Comment
May 1, 2005

Efficient Product Development

by BPI Contributor
Add Comment
May 1, 2005

Compliance By Design

by BPI Contributor
Add Comment
May 1, 2005

Chromatography Advisor #3

by BPI Contributor
Add Comment
May 1, 2005

Building an Electronic Batch Record System

by BPI Contributor
Add Comment
May 1, 2005

Editor’s Choice

  • BioProcess Insider

    Thermo Fisher adds EU viral vector plants in €725m Novasep deal

  • BioProcess Insider

    Moderna has the capacity but cannot guarantee the supply of COVID-19 vaccine

  • Sponsored Content

    FAQs: Challenging host cell protein assays for improved risk mitigation

  • BioProcess Insider

    Up on the downstream: Sartorius to buy Novasep’s chromatography division

  • BioProcess Insider

    Plan to make 1.3bn vaccines in 2021 places strain on Pfizer’s production network

  • Sponsored Content

    The next frontier of CAR-T cell therapies: Allogeneic workflows

BioProcess Insider News and Analysis

Recent Tweets

  • Tweet Avatar RT @melfass: A new podcast from @BioProcessIntl and @Dan5tanton talks about diversity (lack thereof) in the #biopharma workplace. https://t.co/m7oJVSD1ys 2 days ago
  • Tweet Avatar @Regeneron has entered an agreement worth $2.625 billion with the US government and is confident it can supply 1.25… https://t.co/FtAPUmKBxR 3 days ago
  • Tweet Avatar @thermofisher adds EU viral vector plants in €725m @Novasep deal: TF Boosts #CDMO gene therpay biz, while Novasep d… https://t.co/iHylkRjibs 1 week ago
  • Tweet Avatar RT @Dan5tanton: Moderna says it has capacity to deliver 1 billion doses of its mRNA COVID-19 vaccine but with raw materials in high… https://t.co/5e5BAjWjUN 1 week ago
Follow @bioproinsider

Trending

  • BioProcess Insider

    Moderna has the capacity but cannot guarantee the supply of COVID-19 vaccine

  • BioProcess Insider

    Plan to make 1.3bn vaccines in 2021 places strain on Pfizer’s production network

  • BioProcess Insider

    WuXi to make COVID-19 vaccine at shelved Bayer hemophilia drug plant

  • BioProcess Insider

    BMS cites Lonza plant inspection as factor in liso-cel’s ongoing delay

Explore Topics

  • Upstream Processing
  • Downstream Processing
  • Manufacturing
  • Analytical
  • Business

Publication

  • Issue Archive
  • Featured Reports
  • eBooks
  • Subscribe
Connect
Privacy policy

BioProcessIntl.com

  • White Papers
  • Posters
  • Webinars
  • BPI Theater
  • Awards
  • Register
  • Login
  • Access Your Account

Keep up with BPI

  • Email Newsletters
  • Events
  • BioProcess Insider
  • Twitter
  • LinkedIn

About BPI

  • Who We Are
  • Editorial Advisors
  • Author Guidelines
  • Advertising/Media Kit
  • List Rental/Reprints
  • Contact Us
  • Careers
BPI
twitter linkedin
Site Map|Contact
©2021 BioProcess International All Rights reserved
  • Home
  • Current Issue
  • Issue Archive
    â–¼
    • Featured Reports
    • eBooks
  • BioProcess Insider
  • Multimedia
    â–¼
    • BPI White Papers
    • Webinars
    • Posters
  • BioProcess International Events
    â–¼
    • BioProcess International West
    • COVID-19 Therapeutic Development & Production
  • BioProcess International Academy
  • Events